Orsola A - Search Results

1

Cell-specific activation of the HB-EGF and ErbB1 genes by stretch in primary human bladder cells.

Nguyen HT, Park JM, Peters CA, Adam RM, Orsola A, Atala A, Freeman MR. Nguyen HT, et al. Among authors: orsola a. In Vitro Cell Dev Biol Anim. 1999 Jul-Aug;35(7):371-5. doi: 10.1007/s11626-999-0110-9. In Vitro Cell Dev Biol Anim. 1999. PMID: 10462199 No abstract available.

2

Growth and stretch response of human exstrophy bladder smooth muscle cells: molecular evidence of normal intrinsic function.

Orsola A, Estrada CR, Nguyen HT, Retik AB, Freeman MR, Peters CA, Adam RM. Orsola A, et al. BJU Int. 2005 Jan;95(1):144-8. doi: 10.1111/j.1464-410X.2004.05267.x. BJU Int. 2005. PMID: 15638913

3

Heparin-binding EGF-like growth factor is up-regulated in the obstructed kidney in a cell- and region-specific manner and acts to inhibit apoptosis.

Nguyen HT, Bride SH, Badawy AB, Adam RM, Lin J, Orsola A, Guthrie PD, Freeman MR, Peters CA. Nguyen HT, et al. Among authors: orsola a. Am J Pathol. 2000 Mar;156(3):889-98. doi: 10.1016/S0002-9440(10)64958-9. Am J Pathol. 2000. PMID: 10702406 Free PMC article.

4

A novel method for implantation of LNCaP prostate tumor cells under the renal capsule.

Adam RM, Orsola A, Freeman MR. Adam RM, et al. Among authors: orsola a. In Vitro Cell Dev Biol Anim. 2001 Jun;37(6):360-2. doi: 10.1007/BF02577571. In Vitro Cell Dev Biol Anim. 2001. PMID: 11515968 No abstract available.

5

The decision to undergo DNA or protein synthesis is determined by the degree of mechanical deformation in human bladder muscle cells.

Orsola A, Adam RM, Peters CA, Freeman MR. Orsola A, et al. Urology. 2002 May;59(5):779-83. doi: 10.1016/s0090-4295(01)01648-x. Urology. 2002. PMID: 11992928

6

Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function.

Adam RM, Kim J, Lin J, Orsola A, Zhuang L, Rice DC, Freeman MR. Adam RM, et al. Among authors: orsola a. Endocrinology. 2002 Dec;143(12):4599-608. doi: 10.1210/en.2002-220561. Endocrinology. 2002. PMID: 12446587

7

Controlled release of therapeutic agents: slow delivery and cell encapsulation.

Machluf M, Orsola A, Atala A. Machluf M, et al. Among authors: orsola a. World J Urol. 2000 Feb;18(1):80-3. doi: 10.1007/s003450050014. World J Urol. 2000. PMID: 10766049

8

Microencapsulation of Leydig cells: a system for testosterone supplementation.

Machluf M, Orsola A, Boorjian S, Kershen R, Atala A. Machluf M, et al. Among authors: orsola a. Endocrinology. 2003 Nov;144(11):4975-9. doi: 10.1210/en.2003-0411. Epub 2003 Jul 24. Endocrinology. 2003. PMID: 12960073

9

Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.

Wankowicz SAM, Werner L, Orsola A, Novak J, Bowden M, Choueiri TK, de Torres I, Morote J, Freeman GJ, Signoretti S, Bellmunt J. Wankowicz SAM, et al. Among authors: orsola a. J Urol. 2017 Oct;198(4):817-823. doi: 10.1016/j.juro.2017.04.102. Epub 2017 May 6. J Urol. 2017. PMID: 28487100

10

Primary bladder carcinoma in situ: assessment of early BCG response as a prognostic factor.

Orsola A, Palou J, Xavier B, Algaba F, Salvador J, Vicente J. Orsola A, et al. Eur Urol. 1998;33(5):457-63. doi: 10.1159/000019635. Eur Urol. 1998. PMID: 9643664 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters